000			01951 a2200565 4500
005			20250515000732.0
264		0	_c20051229
008			200512s 0 0 eng d
022			_a0022-1899
024	7		_a10.1086/432915 _2doi
040			_aNLM _beng _cNLM
100	1		_aGoepfert, Paul A
245	0	0	_aHigh-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. _h[electronic resource]
260			_bThe Journal of infectious diseases _cOct 2005
300			_a1249-59 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aAIDS Vaccines _xadministration & dosage
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aHIV Antibodies _xblood
650	0	4	_aHIV Seronegativity _ximmunology
650	0	4	_aHIV-1 _ximmunology
650	0	4	_aHumans
650	0	4	_aInterferon-gamma _xmetabolism
650	0	4	_aMale
650	0	4	_aRecombinant Proteins _ximmunology
650	0	4	_aT-Lymphocytes, Cytotoxic _ximmunology
650	0	4	_aTreatment Outcome
650	0	4	_aVaccination
650	0	4	_aVaccines, Synthetic _xadministration & dosage
650	0	4	_aViral Proteins _xgenetics
700	1		_aHorton, Helen
700	1		_aMcElrath, M Juliana
700	1		_aGurunathan, Sanjay
700	1		_aFerrari, Guido
700	1		_aTomaras, Georgia D
700	1		_aMontefiori, David C
700	1		_aAllen, Mary
700	1		_aChiu, Ya-Lin
700	1		_aSpearman, Paul
700	1		_aFuchs, Jonathan D
700	1		_aKoblin, Beryl A
700	1		_aBlattner, William A
700	1		_aFrey, Sharon
700	1		_aKeefer, Michael C
700	1		_aBaden, Lindsey R
700	1		_aCorey, Lawrence
773	0		_tThe Journal of infectious diseases _gvol. 192 _gno. 7 _gp. 1249-59
856	4	0	_uhttps://doi.org/10.1086/432915 _zAvailable from publisher's website
999			_c15772346 _d15772346